Andra AP-fonden’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
|
|||||
|
2025
Q1 | $4.54M | Sell |
|
|||||
|
2024
Q4 | $6.57M | Buy |
|
|||||
|
2024
Q3 | $3.49M | Buy |
|
|||||
|
2024
Q2 | $753K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $6.8M | Buy |
|
|||||
|
2023
Q3 | $6.11M | Sell |
|
|||||
|
2023
Q2 | $7.69M | Sell |
|
|||||
|
2023
Q1 | $9.05M | Sell |
|
|||||
|
2022
Q4 | $13.2M | Buy |
|
|||||
|
2022
Q3 | $9.73M | Buy |
|
|||||
|
2022
Q2 | $6.14M | Buy |
|
|||||
|
2021
Q4 | $4.82M | Buy |
|
|||||
|
2021
Q3 | $3.76M | Buy |
|
|||||
|
2021
Q2 | $2.95M | Buy |
|
|||||
|
2021
Q1 | $2.26M | Sell |
|
|||||
|
2020
Q4 | $2.4M | Buy |
|
|||||
|
2020
Q3 | $2.07M | Sell |
|
|||||
|
2020
Q2 | $5.64M | Buy |
|
|||||
|
2020
Q1 | $3.74M | Buy |
|
|||||
|
2019
Q4 | $1.66M | Buy |
|
|||||
|
2019
Q3 | $225K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $523K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.26M | Sell |
|
|||||
|
2018
Q1 | $1.75M | Buy |
|
|||||
|
2017
Q4 | $241K | Buy |
|